当前位置： SCI文献检索 > MOLECULAR PHARMACOLOGY期刊下所有文献 > Structural Asymmetry of Phosphodiesterase-9A and a Unique Pocket for Selective Binding of a Potent Enantiomeric Inhibitor.

Structural Asymmetry of Phosphodiesterase-9A and a Unique Pocket for Selective Binding of a Potent Enantiomeric Inhibitor.

Abstract：

:Phosphodiesterase-9 (PDE9) inhibitors have been studied as potential therapeutics for treatment of central nervous system diseases and diabetes. Here, we report the discovery of a new category of PDE9 inhibitors by rational design on the basis of the crystal structures. The best compound, (S)-6-((1-(4-chlorophenyl)ethyl)amino)-1-cyclopentyl-1,5,6,7-tetrahydro-4H-pyrazolo[3,4-day]pyrimidin-4-one [(S)-C33], has an IC50 value of 11 nM against PDE9 and the racemic C33 has bioavailability of 56.5% in the rat pharmacokinetic model. The crystal structures of PDE9 in the complex with racemic C33, (R)-C33, and (S)-C33 reveal subtle conformational asymmetry of two M-loops in the PDE9 dimer and different conformations of two C33 enantiomers. The structures also identified a small hydrophobic pocket that interacts with the tyrosyl tail of (S)-C33 but not with (R)-C33, and is thus possibly useful for improvement of selectivity of PDE9 inhibitors. The asymmetry of the M-loop and the different interactions of the C33 enantiomers imply the necessity to consider the whole PDE9 dimer in the design of inhibitors.

journal_name

Mol Pharmacol

journal_title

Molecular pharmacology

authors

Huang M,Shao Y,Hou J,Cui W,Liang B,Huang Y,Li Z,Wu Y,Zhu X,Liu P,Wan Y,Ke H,Luo HB

doi

10.1124/mol.115.099747

subject

Has Abstract

pub_date

2015-11-01 00:00:00

pages

836-45

issue

5

eissn

0026-895X

issn

1521-0111

pii

mol.115.099747

journal_volume

88

pub_type

杂志文章

相关文献

MOLECULAR PHARMACOLOGY文献大全
  • Purification and characterization of the major hepatic cannabinoid hydroxylase in the mouse: a possible member of the cytochrome P-450IIC subfamily.

    abstract：:Acute cannabidiol treatment of mice inactivated hepatic microsomal cytochrome P-450IIIA (P-450IIIA) and markedly inhibited in vitro cannabinoid metabolism. Antibodies raised against purified P-450IIIA inhibited the microsomal formation of quantitatively minor cannabinoid metabolites but had no effect on the major meta...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：

    authors： Bornheim LM,Correia MA

    更新日期：1991-08-01 00:00:00

  • Selective up-regulation of alpha1a-adrenergic receptor protein and mRNA in brown adipose tissue by neural and beta3-adrenergic stimulation.

    abstract：:Previous studies have shown that neural stimulation of brown adipose tissue (BAT) reorganizes the expression and activity of signaling proteins in the beta-adrenergic adenylyl cyclase pathway. Cold stress increases neural stimulation of BAT and increases alpha1-adrenergic receptor number; however, the alpha1 receptor ...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：10.1124/mol.51.4.644

    authors： Granneman JG,Zhai Y,Lahners KN

    更新日期：1997-04-01 00:00:00

  • Dissecting the Signaling Pathways Involved in the Crosstalk between Metabotropic Glutamate 5 and Cannabinoid Type 1 Receptors.

    abstract：:The metabotropic glutamate 5 receptor and the cannabinoid type 1 receptor are G protein-coupled receptors that are widely expressed in the central nervous system. Metabotropic glutamate 5 receptors, present at the postsynaptic site, are coupled to Gαq/11 proteins and display an excitatory response upon activation, whe...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章,评审

    doi：10.1124/mol.116.104372

    authors： Olmo IG,Ferreira-Vieira TH,Ribeiro FM

    更新日期：2016-11-01 00:00:00

  • Geranylgeranylacetone protects membranes against nonsteroidal anti-inflammatory drugs.

    abstract：:Direct gastric mucosal cell damage mediated by nonsteroidal anti-inflammatory drugs (NSAIDs) is involved in the formation of NSAID-induced gastric lesions. We recently suggested that this direct cytotoxicity of NSAIDs is caused by their membrane-permeabilization activity. Geranylgeranylacetone (GGA), a clinically used...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：10.1124/mol.105.015784

    authors： Ushijima H,Tanaka K,Takeda M,Katsu T,Mima S,Mizushima T

    更新日期：2005-10-01 00:00:00

  • Characterization and selective inhibition of cyclic nucleotide phosphodiesterase isozymes in canine tracheal smooth muscle.

    abstract：:Cyclic nucleotide phosphodiesterases (PDEs) from canine trachealis were characterized with respect to their kinetic properties, sensitivity to selective inhibitors, and subcellular distribution. Extracts from whole tissue homogenates were applied to DEAE-Sepharose anion exchange columns and eluted with a linear sodium...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：

    authors： Torphy TJ,Cieslinski LB

    更新日期：1990-02-01 00:00:00

  • Isolation and purification of rat liver morphine UDP-glucuronosyltransferase.

    abstract：:A UDP-glucuronosyltransferase (UDPGT) isoenzyme capable of morphine glucuronidation has been purified to apparent homogeneity and partially characterized from hepatic microsomes of female Wistar rats which have low 3 alpha-hydroxysteroid UDPGT. A rapid and sensitive assay was developed to quantify morphine glucuronide...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：

    authors： Puig JF,Tephly TR

    更新日期：1986-12-01 00:00:00

  • Modulation of peroxisome proliferator-activated receptor delta activity affects neural cell adhesion molecule and polysialyltransferase ST8SiaIV induction by teratogenic valproic acid analogs in F9 cell differentiation.

    abstract：:It has been suggested that the teratogenic effects of the antiepileptic drug valproic acid (VPA) is reflected in vitro by the differentiation of F9 cells, activation of peroxisome proliferator-activated receptor delta (PPARdelta), and inhibition of histone deacetylases (HDACs). The aim of this study was to identify ge...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：10.1124/mol.104.009340

    authors： Lampen A,Grimaldi PA,Nau H

    更新日期：2005-07-01 00:00:00

  • Activation of the c-jun protooncogene in human myeloid leukemia cells treated with etoposide.

    abstract：:The epipodophyllotoxin etoposide is an inhibitor of topoisomerase II. The effects of this agent on gene expression, particularly the transcriptional induction of genes implicated in growth control, are unknown. The present results demonstrate that etoposide induces expression of the c-jun protooncogene in HL-60 myeloi...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：

    authors： Rubin E,Kharbanda S,Gunji H,Kufe D

    更新日期：1991-06-01 00:00:00

  • Mechanisms of cell killing by drugs that trap covalent complexes between DNA topoisomerases and DNA.

    abstract：:DNA topoisomerases are the molecular targets of a range of anticancer and antimicrobial therapeutics. Many of these drugs act by converting their target enzyme to a DNA-damaging agent through the trapping of the covalent enzyme/DNA intermediate. This drug-mediated trapping of the intermediate is reversible, and the le...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：

    authors： Nitiss JL,Wang JC

    更新日期：1996-11-01 00:00:00

  • 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.

    abstract：:Corticotropin-releasing factor (CRF) receptors encoded by two distinct genes have recently been identified and termed CRF1 and CRF2. CRF and the non-mammalian-related peptide sauvagine bind to and activate CRF1 receptors with high affinity and equal potency. Although CRF is significantly weaker at the CRF2 receptor, s...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：

    authors： Grigoriadis DE,Liu XJ,Vaughn J,Palmer SF,True CD,Vale WW,Ling N,De Souza EB

    更新日期：1996-09-01 00:00:00

  • Exposure to diethylstilbestrol during pregnancy modulates microRNA expression profile in mothers and fetuses reflecting oncogenic and immunological changes.

    abstract：:Prenatal exposure to diethylstilbestrol (DES) is known to cause an increased susceptibility to a wide array of clinical disorders in humans. Previous studies from our laboratory demonstrated that prenatal exposure to DES induces thymic atrophy and apoptosis in the thymus. In the current study, we investigated if such ...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：10.1124/mol.114.096743

    authors： Singh NP,Abbas IK,Menard M,Singh UP,Zhang J,Nagarkatti P,Nagarkatti M

    更新日期：2015-05-01 00:00:00

  • Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition.

    abstract：:The L-type amino acid transporter 1 (LAT1) is an Na(+)-independent neutral amino acid transporter subserving the amino acid transport system L. Because of its broad substrate selectivity, system L has been proposed to be responsible for the permeation of amino acid-related drugs through the plasma membrane. To underst...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：10.1124/mol.61.4.729

    authors： Uchino H,Kanai Y,Kim DK,Wempe MF,Chairoungdua A,Morimoto E,Anders MW,Endou H

    更新日期：2002-04-01 00:00:00

  • Specific binding of the novel Na+ channel blocker PD85,639 to the alpha subunit of rat brain Na+ channels.

    abstract：:The local anesthetic-like Na+ channel-blocking drug [3H]PD85639 [alpha-([4-3H]phenyl)-N-[3-(2,6-dimethyl-1-piperizinyl)-alpha-prop yl] [4-3H]benzeneacetamide] binds specifically to receptor sites on Na+ channels in intact synaptosomes and synaptosomal membranes, purified and reconstituted Na+ channels, and type IIA Na...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：

    authors： Thomsen W,Hays SJ,Hicks JL,Schwarz RD,Catterall WA

    更新日期：1993-06-01 00:00:00

  • Atrial natriuretic peptide antagonists: biological evaluation and structural correlations.

    abstract：:A collection of analogues of atrial natriuretic peptide (ANP) were screened for their ability to inhibit ANP-induced cGMP stimulation. The antagonists revealed through this screen are structurally related; almost all are substituted at either aspartate-13 or phenylalanine-26. This tendency is consistent throughout sev...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：

    authors： von Geldern TW,Budzik GP,Dillon TP,Holleman WH,Holst MA,Kiso Y,Novosad EI,Opgenorth TJ,Rockway TW,Thomas AM

    更新日期：1990-12-01 00:00:00

  • A Latin American Perspective on G Protein-Coupled Receptors.

    abstract：:G protein-coupled receptors are sensors that interact with a large variety of elements, including photons, ions, and large proteins. Not surprisingly, these receptors participate in the numerous normal physiologic processes that we refer to as health and in its perturbations that constitute disease. It has been estima...

    journal_title：Molecular pharmacology

    pub_type：

    doi：10.1124/mol.116.106062

    authors： Pupo AS,García-Sáinz JA

    更新日期：2016-11-01 00:00:00

  • Mapping of maurotoxin binding sites on hKv1.2, hKv1.3, and hIKCa1 channels.

    abstract：:Maurotoxin (MTX) is a potent blocker of human voltage-activated Kv1.2 and intermediate-conductance calcium-activated potassium channels, hIKCa1. Because its blocking affinity on both channels is similar, although the pore region of these channels show only few conserved amino acids, we aimed to characterize the bindin...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：10.1124/mol.104.002774

    authors： Visan V,Fajloun Z,Sabatier JM,Grissmer S

    更新日期：2004-11-01 00:00:00

  • Polymorphism and ligand dependent changes in human glucagon-like peptide-1 receptor (GLP-1R) function: allosteric rescue of loss of function mutation.

    abstract：:The glucagon-like peptide-1 receptor (GLP-1R) is a key physiological regulator of insulin secretion and a major therapeutic target for the treatment of type II diabetes. However, regulation of GLP-1R function is complex with multiple endogenous peptides that interact with the receptor, including full-length (1-37) and...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：10.1124/mol.111.072884

    authors： Koole C,Wootten D,Simms J,Valant C,Miller LJ,Christopoulos A,Sexton PM

    更新日期：2011-09-01 00:00:00

  • Oxidative Stress and Response to Thymidylate Synthase-Targeted Antimetabolites.

    abstract：:Thymidylate synthase (TYMS; EC 2.1.1.15) catalyzes the reductive methylation of 2'-deoxyuridine-5'-monophosphate (dUMP) by N(5),N(10)-methyhlenetetrahydrofolate, forming dTMP for the maintenance of DNA replication and repair. Inhibitors of TYMS have been widely used in the treatment of neoplastic disease. A number of ...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：10.1124/mol.115.099614

    authors： Ozer U,Barbour KW,Clinton SA,Berger FG

    更新日期：2015-12-01 00:00:00

  • Disposition of homocysteine and S-3-deazaadenosylhomocysteine in cells exposed to 3-deazaadenosine.

    abstract：:The nucleoside analogue, 3-deazaadenosine (c3-Ado), serves both as a substrate and as an inhibitor of S-adenosylhomocysteine (AdoHcy) hydrolase, and the ability of this compound to induce accumulation of intracellular AdoHcy and S-3-deazaadenosylhomocysteine (c3-AdoHcy) in various cells and species has been widely doc...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：

    authors： Svardal A,Djurhuus R,Ueland PM

    更新日期：1986-08-01 00:00:00

  • CYP2C8 Is a Novel Target of Peroxisome Proliferator-Activated Receptor α in Human Liver.

    abstract：:Human cytochrome P450 (CYP) 2C enzymes metabolize ∼30% of clinically prescribed drugs and various environmental chemicals. CYP2C8, an important member of this subfamily, metabolizes the anticancer drug paclitaxel, certain antidiabetic drugs, and endogenous substrates, including arachidonic acid, to physiologically act...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：10.1124/mol.115.100255

    authors： Makia NL,Goldstein JA

    更新日期：2016-01-01 00:00:00

  • Enhanced detection of receptor constitutive activity in the presence of regulators of G protein signaling: applications to the detection and analysis of inverse agonists and low-efficacy partial agonists.

    abstract：:Fusion proteins between the human 5-hydroxytryptamine (5-HT)(1A) receptor and either wild type or certain pertussis toxin-resistant forms of G(o1)alpha and G(i1)alpha display constitutive GTPase activity that can be inhibited by the inverse agonist spiperone. Addition of recombinant regulator of G protein signaling (R...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：10.1124/mol.61.5.1211

    authors： Welsby PJ,Kellett E,Wilkinson G,Milligan G

    更新日期：2002-05-01 00:00:00

  • Defective adult neurogenesis in CB1 cannabinoid receptor knockout mice.

    abstract：:Pharmacological studies suggest a role for CB1 cannabinoid receptors (CB1R) in regulating neurogenesis in the adult brain. To investigate this possibility, we measured neurogenesis by intraperitoneal injection of bromodeoxyuridine (BrdU), which labels newborn neurons, in wild-type and CB1R-knockout (CB1R-KO) mice. CB1...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：10.1124/mol.66.2.204

    authors： Jin K,Xie L,Kim SH,Parmentier-Batteur S,Sun Y,Mao XO,Childs J,Greenberg DA

    更新日期：2004-08-01 00:00:00

  • Functional interactions between nucleotide binding domains and leukotriene C4 binding sites of multidrug resistance protein 1 (ABCC1).

    abstract：:Multidrug resistance protein 1 (MRP1) is a member of the "C" branch of the ATP-binding cassette transporter superfamily. The NH(2)-proximal nucleotide-binding domain (NBD1) of MRP1 differs functionally from its COOH-proximal domain (NBD2). NBD1 displays intrinsic high-affinity ATP binding and little ATPase activity. I...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：10.1124/mol.104.007708

    authors： Payen L,Gao M,Westlake C,Theis A,Cole SP,Deeley RG

    更新日期：2005-06-01 00:00:00

  • Altered striatal function and muscarinic cholinergic receptors in acetylcholinesterase knockout mice.

    abstract：:Cholinesterase inhibitors are commonly used to improve cognition and treat psychosis and other behavioral symptoms in Alzheimer's disease, Parkinson's disease, and other neuropsychiatric conditions. However, mechanisms may exist that down-regulate the synaptic response to altered cholinergic transmission, thus limitin...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：10.1124/mol.64.6.1309

    authors： Volpicelli-Daley LA,Hrabovska A,Duysen EG,Ferguson SM,Blakely RD,Lockridge O,Levey AI

    更新日期：2003-12-01 00:00:00

  • GPR139, an Orphan Receptor Highly Enriched in the Habenula and Septum, Is Activated by the Essential Amino Acids L-Tryptophan and L-Phenylalanine.

    abstract：:GPR139 is an orphan G-protein-coupled receptor expressed in the central nervous system. To identify its physiologic ligand, we measured GPR139 receptor activity from recombinant cells after treatment with amino acids, orphan ligands, serum, and tissue extracts. GPR139 activity was measured using guanosine 5'-O-(3-[(35...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：10.1124/mol.115.100412

    authors： Liu C,Bonaventure P,Lee G,Nepomuceno D,Kuei C,Wu J,Li Q,Joseph V,Sutton SW,Eckert W,Yao X,Yieh L,Dvorak C,Carruthers N,Coate H,Yun S,Dugovic C,Harrington A,Lovenberg TW

    更新日期：2015-11-01 00:00:00

  • Differential activation of formyl peptide receptor signaling by peptide ligands.

    abstract：:Formyl peptide receptor (FPR) and formyl peptide receptor like 1 (FPRL1) play important roles in inflammation and immunity. Stimulation of FPR and FPRL1 initiates a cascade of signaling events, leading to activation of various phagocyte responses, including chemotaxis, superoxide generation, and exocytosis. Trp-Lys-Ty...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：10.1124/mol.64.4.841

    authors： Bae YS,Song JY,Kim Y,He R,Ye RD,Kwak JY,Suh PG,Ryu SH

    更新日期：2003-10-01 00:00:00

  • Expression profiling of ABC transporters in a drug-resistant breast cancer cell line using AmpArray.

    abstract：:ATP-binding cassette (ABC) membrane proteins comprise a superfamily of transporters with a wide variety of substrates. Humans have 49 members in this superfamily. Several human ABC transporters, such as ABCB1 and ABCC1, have been attributed to cause multidrug resistance (MDR) in cancer treatment when over-expressed. I...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：10.1124/mol.105.011015

    authors： Liu Y,Peng H,Zhang JT

    更新日期：2005-08-01 00:00:00

  • Paclitaxel-induced immune suppression is associated with NF-kappaB activation via conventional PKC isotypes in lipopolysaccharide-stimulated 70Z/3 pre-B lymphocyte tumor cells.

    abstract：:Paclitaxel, a potent antitumor agent, has been shown to be lipopolysaccharide (LPS) mimetic in mice, stimulating signaling pathways and gene expression indistinguishably from LPS. In the present study, we showed the intracellular signaling pathway of paclitaxel-induced nuclear factor-kappaB (NF-kappaB) activation and ...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：10.1124/mol.59.2.248

    authors： Lee M,Jeon YJ

    更新日期：2001-02-01 00:00:00

  • BRCA1 contributes to cell cycle arrest and chemoresistance in response to the anticancer agent irofulven.

    abstract：:Tumor suppressor gene BRCA1 is frequently mutated in familial breast and ovarian cancer. BRCA1 plays pivotal roles in maintaining genomic stability by interacting with numerous proteins in cell cycle control and DNA repair. Irofulven (6-hydroxymethylacylfulvene, HMAF, MGI 114, NSC 683863) is one of a new class of anti...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：10.1124/mol.106.029504

    authors： Wiltshire T,Senft J,Wang Y,Konat GW,Wenger SL,Reed E,Wang W

    更新日期：2007-04-01 00:00:00

  • Genetic polymorphism of human CYP2E1: characterization of two variant alleles.

    abstract：:Ethanol-inducible CYP2E1 is an enzyme of major toxicological interest because it metabolizes several precarcinogens, drugs, and solvents to reactive metabolites. CYP2E1 has also been implicated in alcohol liver disease because of its contribution to oxidative stress. Previously, polymorphic alleles with mutations in i...

    journal_title：Molecular pharmacology

    pub_type： 杂志文章

    doi：

    authors： Hu Y,Oscarson M,Johansson I,Yue QY,Dahl ML,Tabone M,Arincò S,Albano E,Ingelman-Sundberg M

    更新日期：1997-03-01 00:00:00